Skip to main content
Elsevier

PEGylated Nanocarriers

Applications in Drug Delivery

  • 1st Edition -
  • Latest edition
  • Editor: Prashant Kesharwani
  • Language: English

PEGylated Nanocarriers: Applications in Drug Delivery explores the essential properties of PEG that contribute to the creation of long circulating nanocarriers while also examin… Read more

Purchase options

Sorry, this title is not available for purchase in your country/region.

End of Summer Sale

Save up to 30% off

Bright savings for research, study, and discovery

Shop the summer sale

Description

PEGylated Nanocarriers: Applications in Drug Delivery explores the essential properties of PEG that contribute to the creation of long circulating nanocarriers while also examining the significant biological and pharmacological impacts of PEGylation and extended circulation. The book provides a detailed review of the preparation, properties, and applications of various long-circulating PEGylated nanocarriers, such as liposomes, nanoparticles, dendrimers, carbon nanotubes, and more. Key chapters also include analysis of the challenges, biological toxicity, and safety issues associated with PEGylated nanocarriers, enabling better clinical translation.

This book will be of interest to researchers and academics in the fields of biomaterials, pharmaceutical science, and polymer science who have an interest in developing PEGylated drug delivery systems for therapeutics.

Key features

  • Explores PEGylated liposomes, nanoparticles, dendrimers, and nanotubes, detailing their synthesis, properties, and drug delivery applications
  • Covers pharmacokinetics, toxicity, immunogenicity, and regulatory challenges for safe and effective PEGylated drug delivery systems
  • Highlights PEGylated nanocarriers’ role in improving solubility, controlled drug release, in vaccines, and in gene delivery

Readership

Researchers and academics in the fields of biomaterials, pharmaceutical science, and polymer science, with an interest in developing PEGylated drug delivery systems for therapeutics

Table of contents

1. History, Introduction, Basic Method and Types of PEGylation

2. Advantages, Disadvantages and Applications PEGylated Nanocarriers

3. Solubility Enhancement and Drug Release Mechanism by PEGylated Nanocarriers

4. Biofate, Cellular Interactions and Pharmacokinetics of PEGylated Nanocarriers

5. Synthesis and production approaches of pegylated nanocarriers

6. Biological Toxicity, Environmental Hazards Associated and Regulatory Aspects Associated with PEGylated Nanocarriers

7. PEGylated Liposomes: Revolutions in Advanced Drug Delivery

8. PEGylated Nanoemulsions: Revolutions in Advanced Drug Delivery

9. PEGylated Nanomicelles: Revolutions in Advanced Drug Delivery

10. PEGylated Chitosan Nanoparticles: Revolutions in Advanced Drug Delivery

11. PEGylated PLGA Nanoparticles: Revolutions in Advanced Drug Delivery

12. PEGylated Serum Albumin Nanoparticles: Revolutions in Advanced Drug Delivery

13. PEGylated Dendrimers: Revolutions in Advanced Drug Delivery

14. PEGylated Carbon Nanotubes: Revolutions in Advanced Drug Delivery

15. PEGylated Cerium Oxide Nanoparticles: Revolutions in Advanced Drug Delivery

16. PEGylated Silica Nanoparticles: Revolutions in Advanced Drug Delivery

17. PEGylated Gold Nanoparticles: Revolutions in Advanced Drug Delivery

18. PEGylated Silver Nanoparticles: Revolutions in Advanced Drug Delivery

19. PEGylated Magnetic Nanoparticles: Revolutions in Advanced Drug Delivery

20. PEGylated Nanocarriers: A New Frontier in Vaccine Delivery

21. PEGylated Nanocarriers: A New Frontier in Gene Delivery

22. Regulatory Concerns, Future Prospects and Concluding Remarks of PEGylated Nanocarriers

Product details

  • Edition: 1
  • Latest edition
  • Published:
  • Language: English

About the editor

PK

Prashant Kesharwani

Dr. Prashant Kesharwani is an Assistant Professor of Pharmaceutics at Dr. Harisingh Gour Vishwavidyalaya (A Central University), Sagar, India. His work focuses on translational nanomedicine, polymeric biomaterials, targeted drug delivery, nanoengineered drug delivery systems, and translational pharmaceutical research. He has contributed extensively to the scientific literature and has served as an editor of scholarly books. Dr. Kesharwani has received research funding from national agencies and has been recognized with awards and fellowships for his contributions to the field. His research interests include nanomedicine, targeted and stimuli-responsive drug delivery, polymeric nanocarriers, and related pharmaceutical applications. He is actively involved in scientific research, academic mentoring, and scholarly publishing.

Affiliations and expertise
Dr. Harisingh Gour Vishwavidyalaya University, India